![\"When](\"https:\/\/blueheronhealthnews.com\/site\/wp-content\/uploads\/2025\/05\/Neuropathy-449822889.jpg\")
Like most people, you may be wanting to shed a few pounds.<\/p>\nLike most people, you may be wanting to shed a few pounds.<\/p>\n
Especially if you also have type 2 diabetes.<\/p>\n
But there\u2019s one weight loss method you absolutely must avoid.<\/p>\n
Because a new study in the journal JAMA Ophthalmology<\/em> proves it causes Neuropathy.<\/p>\n And this is especially important if you already suffer from Neuropathy.<\/p>\n Like other forms of neuropathy, nonarteritic anterior ischemic optic neuropathy (NAION) happens when blood flow to nerves is reduced.<\/p>\n In this case, it\u2019s blood flow to the optic nerve that carries visual information from your eyes to your brain.<\/p>\n It causes irreversible loss of vision.<\/p>\n For people with diabetes\u2014who already face an increased risk of neuropathy in their retinas\u2014previous reports that linked semaglutide with NAION are pretty alarming.<\/p>\n Semaglutide drugs (sold under brand names like Ozempic and Wegovy) have become hugely popular for treating type 2 diabetes and obesity.<\/p>\n It means that, on top of the blindness risk diabetes already poses, they are now increasing it with the very drug that is supposed to treat their condition.<\/p>\n This worry prompted researchers to take a deeper look.<\/p>\n They pulled data from 14 healthcare databases across the globe, covering over 37 million adults with type 2 diabetes.<\/p>\n They then compared people who had taken semaglutide with those on other diabetes medications between December 2017 and December 2023.<\/p>\n The scientists used two different methods:<\/p>\n 2.\tA self-controlled case series, which looked at patients\u2019 own data over time to see if the risk changed during periods when they were on semaglutide versus periods when they weren\u2019t.\n<\/dd>\n<\/dl>\n They also ran a second, more focused study using a separate database, looking at over 174,000 semaglutide users compared to a matched control group.<\/p>\n Their findings were pretty alarming:<\/p>\n 2.\tCompared with some other medications like empagliflozin, semaglutide was associated with a 127% higher risk when researchers used a very precise definition of NAION.<\/p>\n 3.\tThe self-controlled analysis showed semaglutide use increased the risk of NAION by about 32%.<\/p>\n 4.\tThe risk increased significantly over time\u2014specifically after two years (2.39 times higher risk), three years (2.44 times higher), and four years (2.05 times higher).<\/p>\n 5.\tPeople with both diabetes and high blood pressure had a higher risk.<\/p>\n 6.\tIn one analysis, the risk appeared greater in women than men, although previous smaller studies had shown the opposite.<\/p>\n 7.\tThe risk was especially high in those using Ozempic specifically, with some subgroups showing a risk more than six times higher.\n<\/dd>\n<\/dl>\n This is not the type of neuropathy that we usually think or write about.<\/p>\n But since many people with neuropathy also struggle with diabetes or obesity\u2014and might be tempted to take semaglutide\u2014it is an important warning bell to ring, very loudly.<\/p>\n Fortunately, there is a pretty easy natural way to reverse Neuropathy.<\/p>\n Thousands of readers have already done so by applying the simple diet and lifestyle changes explained here\u2026<\/a><\/strong><\/p>\n\n
\n